Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMC

The glucocorticoid receptor in brown adipocytes is dispensable for control of energy homeostasis

Glantschnig C., Mattijssen F., Vogl ES., Ali Khan A., Rios Garcia M., Fischer K.

Animal Study on Systemic / IV, published in EMBO Rep (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
EMBO Rep (2019)
Reported sample size
—
Source database
Europe PMC
PMID
31559673
PMCID
PMC6832000
DOI
10.15252/embr.201948552
Citations
18

Abstract (original English)

Aberrant activity of the glucocorticoid (GC)/glucocorticoid receptor (GR) endocrine system has been linked to obesity-related metabolic dysfunction. Traditionally, the GC/GR axis has been believed to play a crucial role in adipose tissue formation and function in both, white (WAT) and brown adipose tissue (BAT). While recent studies have challenged this notion for WAT, the contribution of GC/GR signaling to BAT-dependent energy homeostasis remained unknown. Here, we have generated and characterized a BAT-specific GR-knockout mouse (GR BATKO ), for the first time allowing to genetically interrogate the metabolic impact of BAT-GR. The HPA axis in GR BATKO mice was intact, as was the ability of mice to adapt to cold. BAT-GR was dispensable for the adaptation to fasting-feeding cycles and the development of diet-induced obesity. In obesity, glucose and lipid metabolism, insulin sensitivity, and food intake remained unchanged, aligning with the absence of changes in thermogenic gene expression. Together, we demonstrate that the GR in UCP1-positive BAT adipocytes plays a negligible role in systemic metabolism and BAT function, thereby opposing a long-standing paradigm in the field.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsMice, KnockoutMiceBody WeightReceptors, GlucocorticoidFastingEnergy MetabolismHomeostasisAdipocytes, BrownCold-Shock Response

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research